Susan L. Kelley's most recent trade in Dare Bioscience Inc was a trade of 4,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dare Bioscience Inc | Susan L. Kelley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 4,500 | 4,500 | - | - | Stock Option (right to buy) | |
| Dare Bioscience Inc | Susan L. Kelley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Ideaya Biosciences Inc | Susan L. Kelley | Director | 31 May 2024 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | ||
| Dare Bioscience Inc | Susan L. Kelley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Deciphera Pharmaceuticals Inc | Susan L. Kelley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Susan L. Kelley | Director | 07 Jun 2023 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | ||
| Deciphera Pharmaceuticals Inc | Susan L. Kelley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 3,269 | 3,269 | - | - | Stock Option (Right to Buy) | |
| Dare Bioscience Inc | Susan L. Kelley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 38,000 | 38,000 | - | - | Stock Option (right to buy) | |
| Deciphera Pharmaceuticals Inc | Susan L. Kelley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Susan L. Kelley | Director | 09 Jun 2022 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | ||
| Ideaya Biosciences Inc | Susan L. Kelley | Director | 09 Jun 2022 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | ||
| Deciphera Pharmaceuticals Inc | Susan L. Kelley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 9,570 | 9,570 | - | - | Stock Option (Right to Buy) | |
| Dare Bioscience Inc | Susan L. Kelley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Deciphera Pharmaceuticals Inc | Susan L. Kelley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Ideaya Biosciences Inc | Susan L. Kelley | Director | 12 Feb 2021 | 22,000 | 22,000 | - | - | Stock Option (right to buy) | ||
| Ideaya Biosciences Inc | Susan L. Kelley | Director | 12 Feb 2021 | 22,000 | 22,000 | - | - | Stock Option (right to buy) |